Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.44 |
| ▸ | HTR7 | P34969 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7906609 | 0.82 | PNMT (0.50) | PNMTHTR7HTR2BNPC1RAB9A | |
| Hydrochloric Acid SCHEMBL8854105 | 0.77 | PNMT (0.46) | PNMTHTR7HTR2BNPC1RAB9A | |
| Hydrochloric Acid SCHEMBL30021424 | 0.76 | PNMT (0.43) | PNMTHTR7HTR2BNPC1RAB9A | |
| SCHEMBL7518697 | 0.75 | PNMT (0.43) | PNMTHTR7HTR2BNPC1RAB9A | |
| Trifluoroacetic Acid SCHEMBL7518687 | 0.74 | PNMT (0.45) | PNMTHTR7HTR2BNPC1RAB9A | |
| Trifluoroacetic Acid SCHEMBL5553257 | 0.74 | PNMT (0.45) | PNMTHTR7HTR2BNPC1RAB9A | |
| SCHEMBL28463245 | 0.74 | PNMT (0.51) | PNMTHTR7HTR2BNPC1RAB9A | |
| SCHEMBL7518839 | 0.74 | PNMT (0.47) | PNMTHTR7HTR2BNPC1RAB9A | |
| SCHEMBL425742 | 0.73 | PNMT (0.58) | PNMTHTR7HTR2BNPC1RAB9A | |
| SCHEMBL29892750 | 0.73 | PNMT (0.58) | PNMTHTR7HTR2BNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1310510-B1 | Topologically segregated, encoded solid phase libraries | AVENTIS PHARMA INC (US) | 2007-07-11 | — | — | EP | disclosed |
| EP-1310510-A2 | Topologically segregated, encoded solid phase libraries | SELECTIDE CORPORATION (US) | 2003-05-14 | — | — | EP | disclosed |
| EP-0705279-B1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORP (US) | 2003-02-19 | — | — | EP | disclosed |
| US-6090912-A | MULTIPLICITY OF SEPARATE SOLID SUPPORTS WITH SURFACE HAVING SUCEPTIBLE LINKER TO SINGLE SPECIES OF TEST COMPOUND AND WITH INTERIOR HAVING ATTACHED NON-CLEAVABLE CODING MOLECULE; FOR SCREENING LIGANDS OR ACCEPTORS | SELECTIDE CORPORATION (US) | 2000-07-18 | — | — | US | disclosed |
| US-5840485-A | SYNTHETIC TEST COMPOUNDS ATTACHED TO SEPARATE PHASE SYNTHESIS SUPPORTS THAT ALSO CONTAIN CODING MOLECULES THAT ENCODE THE STRUCTURE OF THE SYNTHETIC TEST COMPOUND | SELECTIDE CORPORATION (US) | 1998-11-24 | — | — | US | disclosed |
| WO-1994028028-A1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORPORATION (US) | 1994-12-08 | — | — | WO | disclosed |